Trials / Completed
CompletedNCT03815357
What is the Incidence of an Immune Disorder in Children With Invasive Pneumococcal Disease (IPD)?
What is the Incidence of an Immune Disorder in Children With Invasive Pneumococcal Disease (IPD)? A Prospective Cohort Study.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 380 (actual)
- Sponsor
- Murdoch Childrens Research Institute · Academic / Other
- Sex
- All
- Age
- 0 Months – 18 Years
- Healthy volunteers
- Accepted
Summary
This is a multicentre prospective audit to determine the incidence of immunodeficiency in children with IPD. Aims and/or research question of the project 1. To determine the incidence of primary immunodeficiency in children \>2 years who present with IPD 2. To determine the types of immunodeficiency associated with IPD in children
Conditions
- Invasive Pneumococcal Disease, Recurrent Isolated, 1
- Invasive Pneumococcal Disease, Recurrent Isolated, 2
- Invasive Pneumococcal Disease, Protection Against
- Primary Immunodeficiency
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Referral to Immunology | Screening for primary immunodeficiency including splenic dysfunction |
Timeline
- Start date
- 2017-01-31
- Primary completion
- 2021-06-30
- Completion
- 2021-06-30
- First posted
- 2019-01-24
- Last updated
- 2022-07-06
Locations
6 sites across 2 countries: Australia, New Zealand
Source: ClinicalTrials.gov record NCT03815357. Inclusion in this directory is not an endorsement.